We created a policy because we wanted to:
- Show how responsible or sustainable criteria are factored into investment processes
- Meet current and likely future regulations around taxonomy and reporting requirements.
- Clarify our alignment to and application of Rathbones' responsible investment commitments
With an array of UK retailers struggling and the housing market slump deepening, the team discuss managing exposure to the UK and why they are keeping an eye on the escalating government clampdown on Airbnb. Also, in recognition of National Inclusion Week, the team share how they think about diversity when investing and why Nike, one of the few consumer stocks they hold, is one company that has navigated this area successfully.
Head of multi-asset investments, David Coombs, will give an update on the funds and discuss some of the topics that are front of mind, including his new found love for gilts, fast food and distressed assets.
The team cast their minds back to the days before we knew what COVID was and when inflation was considered conquered to review an investment report they published in 2019 called Ditch the Models. Which of these models the team suggested ditching panned out the way they expected? And are there any others that could do with being ditched today? The swiftly growing animal health sector is the final topic as the team discuss how to avoid the dogs in the space and hopefully end up as the cats who got the cream.
Rathbone Unit Trust Management makes new Executive Chair and Chief Executive appointments as Mike Webb announces retirement
Rathbones Group Plc announces the appointments within Rathbones Unit Trust Management Limited (RUTM) of Jayne Rogers as Executive Chair and Tom Carroll as Chief Executive. Jayne will also take on the role of Chief Distribution Officer, Rathbones Group Plc. This is subject to FCA approval. Both Jayne and Tom will be based in the London office.
The chemicals sector is often the canary in the economic coal mine, so a spate of profit warnings spark a discussion among the team. Meanwhile, is the pent-up demand from COVID-delayed elective surgeries finally coming on stream, and what would it mean for med-tech companies? Finally, the team takes a deep dive on German industrial giant Siemens, which has spent a decade reshaping its business.